Recent advances in UroLift: A comprehensive overview.

Area of Science:

• Urology
• Minimally Invasive Surgery

Background:

• Benign prostate hyperplasia (BPH) significantly impacts lower urinary tract symptoms (LUTS).
• Minimally invasive surgical therapies (MIST) are increasingly utilized for BPH management.
• Prostatic urethral lift (UroLift) is a novel mechanical intervention for BPH.

Purpose of the Study:

• To evaluate the efficacy and safety of UroLift for BPH treatment.
• To assess UroLift's impact on LUTS, quality of life (QoL), and sexual health.
• To compare UroLift with traditional BPH treatments.

Main Methods:

• A decade-long narrative synthesis of UroLift studies.
• Evaluation of International Prostate Symptom Score (IPSS), QoL, Qmax, and sexual function metrics.
• Comparative analysis with transurethral resection of the prostate (TURP).

Main Results:

• UroLift demonstrated significant improvements in objective BPH parameters.
• The procedure exhibits a low side-effect profile.
• UroLift shows comparable QoL changes to TURP, with superior recovery time and ejaculatory function preservation.

Conclusions:

• UroLift is a viable treatment option for BPH patients prioritizing sexual and ejaculatory function.
• Further research is required to define optimal patient eligibility and long-term outcomes for UroLift.